The results revealed that total levels of IgG2 and IgA1 were not significantly changed, and different glycoform on Igs exhibited different expression patterns in the progression of HBV-HCC (Fig. 7B). The gene discussed is IGHA1; the disease is hepatocellular carcinoma.